159 related articles for article (PubMed ID: 15919128)
21. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
[TBL] [Abstract][Full Text] [Related]
23. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers.
Zhu J; Zhou Z; Yang C; Kong D; Wan Y; Wang Z
J Biomed Mater Res A; 2011 Jun; 97(4):498-508. PubMed ID: 21509931
[TBL] [Abstract][Full Text] [Related]
24. Formulation of PEG-ylated L-asparaginase loaded poly (lactide-co-glycolide) nanoparticles: influence of Pegylation on enzyme loading, activity and in vitro release.
Vasudev SS; Ahmad S; Parveen R; Ahmad FJ; Anish CK; Ali M; Panda AK
Pharmazie; 2011 Dec; 66(12):956-60. PubMed ID: 22312702
[TBL] [Abstract][Full Text] [Related]
25. Effect of the molecular weight of poly(ethylene glycol) used as emulsifier on alpha-chymotrypsin stability upon encapsulation in PLGA microspheres.
Castellanos IJ; Flores G; Griebenow K
J Pharm Pharmacol; 2005 Oct; 57(10):1261-69. PubMed ID: 16259754
[TBL] [Abstract][Full Text] [Related]
26. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
[TBL] [Abstract][Full Text] [Related]
27. Preparation of a Thermosensitive Gel Composed of a mPEG-PLGA-PLL-cRGD Nanodrug Delivery System for Pancreatic Tumor Therapy.
Shen M; Xu YY; Sun Y; Han BS; Duan YR
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20530-7. PubMed ID: 26366977
[TBL] [Abstract][Full Text] [Related]
28. A novel approach to biodegradable block copolymers of epsilon-caprolactone and delta-valerolactone catalyzed by new aluminum metal complexes.
Yang J; Jia L; Yin L; Yu J; Shi Z; Fang Q; Cao A
Macromol Biosci; 2004 Dec; 4(12):1092-104. PubMed ID: 15586386
[TBL] [Abstract][Full Text] [Related]
29. Role of a novel multifunctional excipient poly(ethylene glycol)-block-oligo(vinyl sulfadimethoxine) in controlled release of lysozyme from PLGA microspheres.
Taluja A; Bae YH
Int J Pharm; 2008 Jun; 358(1-2):50-9. PubMed ID: 18395374
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
[TBL] [Abstract][Full Text] [Related]
31. Analyses of functional polymer-modified nanoparticles for protein sensing by surface-assisted laser desorption/ionization mass spectrometry coupled with HgTe nanomatrices.
Chang HY; Huang MF; Hsu CL; Huang CC; Chang HT
Colloids Surf B Biointerfaces; 2015 Jun; 130():157-63. PubMed ID: 25896538
[TBL] [Abstract][Full Text] [Related]
32. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
33. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.
Luo G; Yu X; Jin C; Yang F; Fu D; Long J; Xu J; Zhan C; Lu W
Int J Pharm; 2010 Jan; 385(1-2):150-6. PubMed ID: 19825404
[TBL] [Abstract][Full Text] [Related]
34. Preparation of uniform-sized PELA microspheres with high encapsulation efficiency of antigen by premix membrane emulsification.
Wei Q; Wei W; Tian R; Wang LY; Su ZG; Ma GH
J Colloid Interface Sci; 2008 Jul; 323(2):267-73. PubMed ID: 18501376
[TBL] [Abstract][Full Text] [Related]
35. Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin.
Kunii R; Onishi H; Machida Y
Eur J Pharm Biopharm; 2007 Aug; 67(1):9-17. PubMed ID: 17337172
[TBL] [Abstract][Full Text] [Related]
36. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2004 Jun; 25(14):2843-9. PubMed ID: 14962562
[TBL] [Abstract][Full Text] [Related]
37. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
38. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
39. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
40. Room-temperature preparation and characterization of poly (ethylene glycol)-coated silica nanoparticles for biomedical applications.
Xu H; Yan F; Monson EE; Kopelman R
J Biomed Mater Res A; 2003 Sep; 66(4):870-9. PubMed ID: 12926040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
